L. Beaumont

437 total citations
6 papers, 69 citations indexed

About

L. Beaumont is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, L. Beaumont has authored 6 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in L. Beaumont's work include Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Transplantation: Methods and Outcomes (2 papers). L. Beaumont is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Transplantation: Methods and Outcomes (2 papers). L. Beaumont collaborates with scholars based in France. L. Beaumont's co-authors include Manon Launay, R. Guillemain, Eliane M. Billaud, Lucien Lécuyer, Antoine Roux, Dominique Grenet, Benoît Douvry, C. Picard, Joëlle Guitard and Richard Dorent and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and European Respiratory Journal.

In The Last Decade

L. Beaumont

6 papers receiving 69 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Beaumont France 4 31 31 27 22 7 6 69
Kenneth McCurry United States 1 33 1.1× 10 0.3× 22 0.8× 48 2.2× 4 0.6× 4 65
Alfredo Puing United States 5 21 0.7× 12 0.4× 15 0.6× 21 1.0× 12 52
M. A. Gomez-Sanchez Spain 4 28 0.9× 21 0.7× 6 0.2× 34 1.5× 6 0.9× 10 59
Isabella Abbasciano Italy 3 31 1.0× 60 1.9× 7 0.3× 14 0.6× 3 0.4× 4 74
Tarunjeet Klair United States 6 65 2.1× 46 1.5× 15 0.6× 7 0.3× 15 2.1× 8 93
María V. Mogollón Spain 5 29 0.9× 12 0.4× 9 0.3× 21 1.0× 44 6.3× 9 97
Marie Lecronier France 4 4 0.1× 10 0.3× 26 1.0× 8 0.4× 9 1.3× 10 55
Tim Maggs United Kingdom 4 10 0.3× 21 0.7× 9 0.3× 6 0.3× 2 0.3× 7 45
R. Quigley United Kingdom 4 43 1.4× 11 0.4× 7 0.3× 6 0.3× 3 0.4× 7 55
Delphine Kervella France 7 103 3.3× 54 1.7× 6 0.2× 3 0.1× 3 0.4× 24 128

Countries citing papers authored by L. Beaumont

Since Specialization
Citations

This map shows the geographic impact of L. Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Beaumont more than expected).

Fields of papers citing papers by L. Beaumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Beaumont. The network helps show where L. Beaumont may publish in the future.

Co-authorship network of co-authors of L. Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of L. Beaumont. A scholar is included among the top collaborators of L. Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Beaumont. L. Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Brugière, Olivier, Alexandre Vallée, Quentin Raimbourg, et al.. (2023). Conversion to belatacept after lung transplantation: Report of 10 cases. PLoS ONE. 18(3). e0281492–e0281492. 8 indexed citations
2.
Dauriat, Gaëlle, L. Beaumont, Liêm Binh Luong Nguyen, et al.. (2022). Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study. European Respiratory Journal. 61(1). 2200502–2200502. 16 indexed citations
3.
Brugière, Olivier, Mathilde Neuville, Yves Le Tulzo, et al.. (2021). COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids. Experimental and Clinical Transplantation. 19(7). 744–748. 3 indexed citations
4.
Launay, Manon, Joëlle Guitard, Richard Dorent, et al.. (2019). Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients. American Journal of Transplantation. 20(2). 553–563. 22 indexed citations
5.
Launay, Manon, Antoine Roux, L. Beaumont, et al.. (2018). Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. 62(3). 19 indexed citations
6.
Beaumont, L. & F. Vaylet. (2014). Comment traiter les cancers bronchiques stade III des sujets âgés ?. Revue des Maladies Respiratoires Actualités. 6(2). e7–e10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026